Important: The POPLINE website will retire on September 1, 2019. Click here to read about the transition.

Your search found 2 Results

  1. 1
    312464

    Guidelines for the programmatic management of drug-resistant tuberculosis.

    Rich M; Cegielski P; Jaramillo E; Lambregts K

    Geneva, Switzerland, World Health Organization [WHO], Stop TB Department, 2006. [184] p. (WHO/HTM/TB/2006.361)

    The emergence of resistance to drugs used to treat tuberculosis (TB), and particularly multidrug-resistant TB (MDR-TB), has become a significant public health problem in a number of countries and an obstacle to effective global TB control. In many other countries, the extent of drug resistance is unknown and the management of patients with MDR-TB is inadequate. In countries where drug resistance has been identified, specific measures need to be taken within TB control programmes to address the problem through appropriate management of patients and adoption of strategies to prevent the propagation and dissemination of drug-resistant TB, including MDR-TB. These guidelines offer updated recommendations for TB control programmes and medical workers in middle- and low-income countries faced with drug-resistant forms of TB, especially MDR-TB. They replace two previous publications by the World Health Organization (WHO) on drug-resistant TB. Taking account of important developments in recent years, the new guidelines aim to disseminate consistent, up-to-date recommendations for national TB control programmes and medical practitioners on the diagnosis and management of drug-resistant TB in a variety of geographical, political, economic and social settings. The guidelines can be adapted to suit diverse local circumstances because they are structured around a flexible framework approach, combining a consistent core of principles and requirements with various alternatives that can be tailored to the specific local situation. (excerpt)
    Add to my documents.
  2. 2
    303738

    Tuberculosis and AIDS: UNAIDS point of view.

    Joint United Nations Programme on HIV / AIDS [UNAIDS]

    Geneva, Switzerland, UNAIDS, 1997 Oct. 7 p. (UNAIDS Best Practice Collection; UNAIDS Point of View)

    The TB germ, a bacterium called Mycobacterium tuberculosis, is highly prevalent in much of the developing world and in poor urban "pockets" of industrialized countries. In these communities, people typically become infected in childhood. But a healthy immune system usually keeps the infection in check. People can remain infected for life with dormant, uninfectious TB. Such people are called TB carriers. In the past, most TB- infected people remained healthy carriers. Only 5-10% ever developed active tuberculosis. Those few kept the TB epidemic alive by transmitting the TB germ to their close contacts. TB germs can be spread through the air from patients with active pulmonary (lung) tuberculosis. Today, as TB carriers increasingly become infected with HIV, many more are developing active tuberculosis because the virus is destroying their immune system. For these dually infected people, the risk of developing active tuberculosis is 30-50-fold higher than for people infected with TB alone. (excerpt)
    Add to my documents.